Legend Biotech ROA 2019-2022 | LEGN
Current and historical return on assets (ROA) values for Legend Biotech (LEGN) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Legend Biotech ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2022-03-31 |
$-0.35B |
$1.04B |
-36.07% |
| 2021-12-31 |
$-0.39B |
$1.12B |
-45.24% |
| 2021-09-30 |
$-0.36B |
$0.81B |
-47.07% |
| 2021-06-30 |
$-0.30B |
$0.88B |
-40.82% |
| 2021-03-31 |
$-0.34B |
$0.62B |
-48.40% |
| 2020-12-31 |
$-0.30B |
$0.72B |
-47.35% |
| 2020-09-30 |
$-0.31B |
$0.71B |
-58.08% |
| 2020-06-30 |
$-0.27B |
$0.77B |
-76.02% |
| 2020-03-31 |
$-0.17B |
$0.37B |
-101.07% |
| 2019-12-31 |
$-0.13B |
$0.29B |
-184.72% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$8.835B |
$0.090B |
|
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's lead product consist LCAR-B38M/JNJ-4528, which are in clinical stage. Legend Biotech Corporation is based in Cayman Islands.
|
